SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-091271
Filing Date
2021-03-23
Accepted
2021-03-23 16:45:52
Documents
3
Period of Report
2021-03-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d161394d8k.htm 8-K 21125
2 EX-3.1 d161394dex31.htm EX-3.1 30139
3 EX-3.2 d161394dex32.htm EX-3.2 152623
  Complete submission text file 0001193125-21-091271.txt   205064
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40227 | Film No.: 21765339
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences